Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus Infection

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2014 by Yonsei University.
Recruitment status was:  Active, not recruiting
Sponsor:
Collaborators:
Bristol-Myers Squibb
Seoul St. Mary's Hospital
The Catholic University of Korea
Information provided by (Responsible Party):
Sang Hoon Ahn, Yonsei University
ClinicalTrials.gov Identifier:
NCT01594905
First received: May 7, 2012
Last updated: January 30, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2014
  Estimated Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)